Synthetic cannabinoids are a class of drugs designed to have similar structures and biological activities as the psychoactive components in cannabis. This encompasses a wide range of structural variants, and their potencies and toxicities are not fully understood. This trade publication piece summarizes the history of synthetic cannabinoids and highlights the ongoing challenge they present to public health and interdiction efforts.
Downloads
Similar Publications
- The cross-reactivity of cannabinoid analogs (delta-8-THC, delta-10-THC and CBD), their metabolites and chiral carboxy HHC metabolites in urine of six commercially available homogeneous immunoassays
- Restoring Promise: Positive Research Results from a Program that Aims to Transform Correctional Culture
- Evaluating a Multi-Disciplinary Response to Domestic Violence: The DVERT Program in Colorado Springs